Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Roger Lehmann
Erratum to “2019 ESC/EAS Guidelines for the Management of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk” [Atherosclerosis 290 (2019) 140–205]
Atherosclerosis
Cardiovascular Medicine
Cardiology
Diabetes Und Urogenitale Infektionen Unter SGLT2-Hemmern
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
Related publications
ESC/EAS Guidelines for the Management of Dyslipidaemias
Atherosclerosis
Cardiovascular Medicine
Cardiology
ESC/EAS Guidelines for the Management of Dyslipidaemias
Revista española de cardiología (English ed.)
Medicine
2018 ESC Guidelines for the Management of Cardiovascular Diseases During Pregnancy
Kardiologia Polska
Cardiovascular Medicine
Cardiology
Pharmacotherapy of Pulmonary Hypertension (According to the 2015 ESC/EAS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension)
Rational Pharmacotherapy in Cardiology
Cardiovascular Medicine
Pharmacology
Cardiology
Revised Guidelines for Cardiovascular Risk Management
British Journal of General Practice
Medicine
Family Practice
2019 Guidelines for the Management of Hypertension — Part 1–7
Arterial Hypertension
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Guidelines to the Practice of Anesthesia – Revised Edition 2019
Canadian Journal of Anaesthesia
Medicine
Anesthesiology
Pain Medicine
The ESC 2019 CCS Guidelines: Have We Left Our Patients and Scientific Evidence Behind?
European Journal of Internal Medicine
Internal Medicine
Trials in “True” Dyslipidemic Patients Are Urged to Reconsider Comprehensive Lipid Management as a Means to Reduce Residual Cardiovascular Risk
Clinical Pharmacology and Therapeutics
Pharmacology
